Table 2. Scan parameters for selected applications.
Technique | Gating technique | Contrast technique | Coverage | Slice thickness | Medications |
---|---|---|---|---|---|
Coronary artery assessment | Prospective | Biphasic | Carina to diaphragm | 0.9 mm × 0.5 mm | Nitroglycerin 0.4 mg sublingual |
Metoprolol (50–100 mg PO; 5–25 mg IV) | |||||
Functional evaluation | Retrospective | Triphasic | Carina to diaphragm | 2 mm × 1 mm | None |
Perfusion (stress) | Prospective | Biphasic | Carina to diaphragm | 0.9 mm × 0.5 mm | Stress agent (regadenoson 0.4 mg over 10 s; adenosine 140 ìg/kg/min for at least 2 min) |
Perfusion (rest) | Prospective | Biphasic | Carina to diaphragm | 0.9 mm × 0.5 mm | Nitroglycerin 0.4 mg sublingual |
Metoprolol (50–100 mg PO; 5–25 mg IV) | |||||
Delayed enhancement | Prospective | No additional contrast than the early phase | Carina to diaphragm | 0.9 mm × 0.5 mm | No additional medication |
PO, per os (orally); IV, intravenous.